Clinical trial
Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic…
NCT00111904 · Theradex, Industry · Completed
Key facts
| NCT number | NCT00111904 |
|---|---|
| Title | Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer |
| Official title | Phase II Clinical Trial of Genexol -PM in Patients With Advanced Pancreatic Cancer |
| Lead sponsor | Theradex, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | paclitaxel-loaded polymeric micelle |
| Enrollment | 43 |
| Start date | May 1, 2005 |
| Primary completion | Aug 1, 2007 |
| First posted | May 27, 2005 |
| Last update posted | Dec 14, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: